参考文献/References:
[1] Hao G,Wang X,Chen Z,et al. Prevalence of heart failure and left ventricular dysfunction in China:the China Hypertension Survey,2012-2015[J]. Eur J Heart Fail,2019,21(11):1329-1337.
[2] Fülster S,Tacke M,Sandek A,et al. Muscle wasting in patients with chronic heart failure:results from the studies investigating co-morbidities aggravating heart failure(SICA-HF)[J]. Eur Heart J,2013,34(7):512-519.
[3] Cruz-Jentoft AJ,Bahat G,Bauer J,et al. Sarcopenia:revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(1):16-31.
[4] Mancini DM,Walter G,Reichek N,et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure[J]. Circulation,1992,85(4):1364-1373.
[5] Haykowsky MJ,Brubaker PH,Morgan TM,et al. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction:role of lean body mass[J]. J Gerontol A Biol Sci Med Sci,2013,68(8):968-975.
[6] Emami A,Saitoh M,Valentova M,et al. Comparison of sarcopenia and cachexia in men with chronic heart failure:results from the Studies Investigating Co-morbidities Aggravating Heart Failure(SICA-HF)[J]. Eur J Heart Fail,2018,20(11):1580-1587.
[7] Rahman A,Jafry S,Jeejeebhoy K,et al. Malnutrition and cachexia in heart failure[J]. JPEN J Parenter Enteral Nutr,2016,40(4):475-486.
[8] Porto JM,Nakaishi APM,Cangussu-Oliveira LM,et al. Relationship between grip strength and global muscle strength in community-dwelling older people[J]. Arch Gerontol Geriatr,2019,82:273-278.
[9] Loncar G,Bozic B,von Haehling S,et al. Association of adiponectin with peripheral muscle status in elderly patients with heart failure[J]. Eur J Intern Med,2013,24(8):818-823.
[10] Konishi M,Kagiyama N,Kamiya K,et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction[J]. Eur J Prev Cardiol,2021,28(9):1022-1029.
[11] Weng SC,Lin CS,Tarng DC,et al. Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction:a retrospective longitudinal study[J]. BMC Geriatr,2021,21(1):92.
[12] Parahiba SM,Spillere SR,Zuchinali P,et al. Handgrip strength in patients with acute decompensated heart failure:accuracy as a predictor of malnutrition and prognostic value[J]. Nutrition,2021,91-92:111352.
[13] Pavasini R,Serenelli M,Celis-Morales CA,et al. Grip strength predicts cardiac adverse events in patients with cardiac disorders:an individual patient pooled meta-analysis[J]. Heart,2019,105(11):834-841.
[14] World Health Organisation. Towards a common language for functioning,disability and health:ICF[M]. Geneva:World Health Organisation,2002.
[15] Cruz-Jentoft AJ,Baeyens JP,Bauer JM,et al. Sarcopenia:European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing,2010,39(4):412-423.
[16] Mentz RJ,Whellan DJ,Reeves GR,et al. Rehabilitation intervention in older patients with acute heart?failure with?preserved versus reduced ejection?fraction[J]. JACC Heart Fail,2021,9(10):747-757.
[17] Iwatsu K,Ikeda T,Matsumura K,et al. Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure[J]. Int J Cardiol,2022,361:85-90.
[18] Enright PL. The six-minute walk test[J]. Respir Care,2003,48(8):783-785.
[19] Faggiano P,D’Aloia A,Gualeni A,et al. The 6 minute walking test in chronic heart failure:indications,interpretation and limitations from a review of the literature[J]. Eur J Heart Fail,2004,6(6):687-691.
[20] Del Buono MG,Arena R,Borlaug BA,et al. Exercise intolerance in patients with heart failure:JACC state-of-the-art review[J]. J Am Coll Cardiol,2019,73(17):2209-2225.
[21] Peeters P,Mets T. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure[J]. J Gerontol A Biol Sci Med Sci,1996,51(4):M147-M151.
[22] Rostagno C,Olivo G,Comeglio M,et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure:comparison with other methods of functional evaluation[J]. Eur J Heart Fail,2003,5(3):247-252.
[23] Studenski S,Perera S,Patel K,et al. Gait speed and survival in older adults[J]. JAMA,2011,305(1):50-58.
[24] Lo AX,Donnelly JP,McGwin G Jr,et al. Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults≥65?years with heart failure[J]. Am J Cardiol,2015,115(6):797-801.
[25] Chaudhry SI,McAvay G,Chen S,et al. Risk factors for hospital admission among older persons with newly diagnosed heart failure:findings from the Cardiovascular Health Study[J]. J Am Coll Cardiol,2013,61(6):635-642.
[26] Ozawa T,Yamashita M,Seino S,et al. Standardized gait speed ratio in elderly patients with heart failure[J]. ESC Heart Fail,2021,8(5):3557-3565.
[27] Pulignano G,Del Sindaco D,di Lenarda A,et al. Incremental value of gait speed in predicting prognosis of older adults with heart failure:insights from the IMAGE-HF study[J]. JACC Heart Fail,2016,4(4):289-298.
[28] Drexler H,Riede U,Münzel T,et al. Alterations of skeletal muscle in chronic heart failure[J]. Circulation,1992,85(5):1751-1759.
[29] Seiler M,Bowen TS,Rolim N,et al. Skeletal muscle alterations are exacerbated in heart failure with reduced compared with preserved ejection fraction:mediated by circulating cytokines?[J]. Circ Heart Fail,2016,9(9):e003027.
[30] Mettauer B,Zoll J,Sanchez H,et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects[J]. J Am Coll Cardiol,2001,38(4):947-954.
[31] Hambrecht R,Adams V,Gielen S,et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle[J]. J Am Coll Cardiol,1999,33(1):174-179.
[32] Kitzman DW,Nicklas B,Kraus WE,et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction[J]. Am J Physiol Heart Circ Physiol,2014,306(9):H1364-H1370.
[33] Newman AB,Simonsick EM,Naydeck BL,et al. Association of long-distance corridor walk performance with mortality,cardiovascular disease,mobility limitation,and disability[J]. JAMA,2006,295(17):2018-2026.
[34] Kadariya D,Canada JM,Del Buono MG,et al. Peak oxygen uptake recovery delay after maximal exercise in patients with heart failure[J]. J Cardiopulm Rehabil Prev,2020,40(6):434-437.
[35] Vale-Lira A,Turri-Silva N,Verboven K,et al. Muscle-skeletal abnormalities and muscle oxygenation during isokinetic strength exercise in heart failure with preserved ejection fraction phenotype:a cross-sectional study[J]. Int J Environ Res Public Health,2022,19(2):709.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(9):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(9):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(9):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(9):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(9):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(9):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]